Keith Steward's Colleagues at QED Therapeutics
Keith Steward's Contact Details
HQ
650-231-4088
650-231-4088
Location
United States
United States
Company
QED Therapeutics
QED Therapeutics
Keith Steward's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Keith Steward
Keith Steward currently works for QED Therapeutics.
Keith Steward's role at QED Therapeutics is Vice President Global Medical Affairs.
Keith Steward's email address is ***@qedtx.com. To view Keith Steward's full email address, please signup to ConnectPlex.
Keith Steward works in the Research industry.
Keith Steward's colleagues at QED Therapeutics are Roo Vold, Joyce Velez, Richard Jones, Cortney Galasso, Kim Ho, Vanessa Solis, Morgan Paull and others.
Keith Steward's phone number is 650-231-4088